Irritable Bowel Syndrome

IBS-D features rapid colonic transit causing loose, frequent stools and urgency. IBS-C involves delayed transit resulting in infrequent bowel movements, straining, and hard stools. IBS-M alternates between both patterns, producing bloating, abdominal discomfort, and incomplete evacuation sensations. These distinct motility patterns define each subtype's clinical presentation.

The gut-brain axis integrates neural, hormonal, and immune signaling between the central nervous system and gastrointestinal tract. In IBS, dysregulation of this two-way communication system allows stress and emotional states to amplify gastrointestinal symptoms by modulating motility, pain perception, and immune responses.

Dysbiosis occurs when harmful bacteria outnumber beneficial ones, triggering immune pathways and increasing gas production. These microbial imbalances disrupt normal bowel rhythms and fermentation patterns. Shifts toward pro-inflammatory bacteria further disturb motility and exacerbate symptoms, reinforcing the cycle of gastrointestinal dysfunction.

Visceral hypersensitivity causes exaggerated pain or discomfort responses to normal intestinal stimuli due to enhanced sensory signaling in peripheral nerves and central processing pathways. This abnormal sensory processing makes patients perceive routine gut sensations as painful, significantly impacting quality of life and symptom severity.

Increased intestinal permeability, sometimes called leaky gut, allows luminal bacteria and metabolites to cross the epithelial barrier. This promotes low-grade inflammation, which reinforces visceral hypersensitivity and alters motility patterns. The resulting immune activation perpetuates the cycle of gastrointestinal dysfunction characteristic of IBS.

IBS involves interconnected disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut-brain communication. These mechanisms interact dynamically to produce heterogeneous symptoms that vary across IBS subtypes. No single factor alone explains IBS; rather, the combination of multiple pathophysiological mechanisms drives disease presentation.

IBS is a functional disorder characterized by altered motility and sensory processing without structural damage, while inflammatory bowel disease involves chronic inflammation and tissue damage. Understanding these distinctions is important for diagnosis and treatment. Comparing inflammatory bowel disease clinical manifestations helps clarify why IBS symptoms persist despite normal endoscopic findings.